Cabaletta Bio Inc
CABA1.500USD
+0.060+4.17%
Fechamento 08/04, 16:00（ET）Cotações atrasadas em 15 min
76.11MValor de mercado
PerdaP/L TTM
Mais detalhes de Cabaletta Bio Inc Empresa
Cabaletta Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on the discovery and development of engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administration for patients with autoimmune diseases. Its Cabaletta Approach to B cell Ablation (CABA) platform encompasses two strategies: Chimeric Antigen Receptor T cells for Autoimmunity (CARTA) and Chimeric AutoAntibody Receptor T cells (CAART). CABA-201, its lead product candidate from its CARTA platform, is a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T construct designed to treat patients with a range of autoimmune diseases. Its DSG3-CAART product candidate is being evaluated for the treatment of mPV, a subtype of PV that affects the epithelium of the mucous membranes, in the Phase 1 DesCAARTes TM trial. Its MuSK-CAART product candidate is designed to treat a subset of patients with MG, targeting autoreactive B cells.
Informações da empresa
Código da empresaCABA
Nome da EmpresaCabaletta Bio Inc
Data de listagemOct 25, 2019
CEODr. Steven Nichtberger, M.D.
Número de funcionários161
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 25
Endereço2929 Arch Street
CidadePHILADELPHIA
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal19104
Telefone12677593100
Sitehttps://www.cabalettabio.com/
Código da empresaCABA
Data de listagemOct 25, 2019
CEODr. Steven Nichtberger, M.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Steven Nichtberger, M.D.
Dr. Steven Nichtberger, M.D.
Chief Executive Officer, President, Chairman of the Board, Co-Founder
Chief Executive Officer, President, Chairman of the Board, Co-Founder
1.35M
-30.78%
Dr. Scott C. Brun, M.D.
Dr. Scott C. Brun, M.D.
Independent Director
Independent Director
--
--
Dr. David J. Chang, M.D.
Dr. David J. Chang, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Catherine Bollard, M.D.
Dr. Catherine Bollard, M.D.
Independent Director
Independent Director
--
--
Mr. Mark J. Simon
Mr. Mark J. Simon
Independent Director
Independent Director
--
--
Ms. Shawn Cline Tomasello
Ms. Shawn Cline Tomasello
Independent Director
Independent Director
--
--
Mr. Richard Conover Henriques, Jr.
Mr. Richard Conover Henriques, Jr.
Independent Director
Independent Director
--
--
Dr. Gwendolyn Knowlton (Gwen) Binder-Scholl, Ph.D.
Dr. Gwendolyn Knowlton (Gwen) Binder-Scholl, Ph.D.
President - Science and Technology
President - Science and Technology
--
--
Dr. Arun Das, M.D.
Dr. Arun Das, M.D.
Chief Business Officer
Chief Business Officer
--
--
Mr. Anup Marda
Mr. Anup Marda
Chief Financial Officer
Chief Financial Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Steven Nichtberger, M.D.
Dr. Steven Nichtberger, M.D.
Chief Executive Officer, President, Chairman of the Board, Co-Founder
Chief Executive Officer, President, Chairman of the Board, Co-Founder
1.35M
-30.78%
Dr. Scott C. Brun, M.D.
Dr. Scott C. Brun, M.D.
Independent Director
Independent Director
--
--
Dr. David J. Chang, M.D.
Dr. David J. Chang, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Catherine Bollard, M.D.
Dr. Catherine Bollard, M.D.
Independent Director
Independent Director
--
--
Mr. Mark J. Simon
Mr. Mark J. Simon
Independent Director
Independent Director
--
--
Ms. Shawn Cline Tomasello
Ms. Shawn Cline Tomasello
Independent Director
Independent Director
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: ter, 24 de jun
Atualizado em: ter, 24 de jun
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Jennison Associates LLC
6.69%
Citadel Advisors LLC
5.36%
T. Rowe Price Investment Management, Inc.
4.41%
Adage Capital Management, L.P.
4.04%
The Vanguard Group, Inc.
3.84%
Other
75.66%
Investidores
Investidores
Proporção
Jennison Associates LLC
6.69%
Citadel Advisors LLC
5.36%
T. Rowe Price Investment Management, Inc.
4.41%
Adage Capital Management, L.P.
4.04%
The Vanguard Group, Inc.
3.84%
Other
75.66%
Tipos de investidores
Investidores
Proporção
Investment Advisor
21.50%
Hedge Fund
13.30%
Investment Advisor/Hedge Fund
9.13%
Research Firm
2.25%
Individual Investor
1.68%
Bank and Trust
0.14%
Pension Fund
0.02%
Other
51.98%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
332
43.19M
48.02%
-20.01M
2025Q1
343
38.78M
72.92%
-24.88M
2024Q4
342
40.39M
82.63%
-20.01M
2024Q3
330
50.24M
102.85%
-12.34M
2024Q2
325
53.21M
110.27%
-11.74M
2024Q1
310
53.11M
110.79%
-5.05M
2023Q4
269
50.62M
118.36%
-623.67K
2023Q3
244
42.61M
108.50%
-4.28M
2023Q2
218
38.30M
97.94%
+637.03K
2023Q1
208
26.57M
91.08%
-5.98M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Jennison Associates LLC
2.43M
2.71%
-78.33K
-3.12%
Mar 31, 2025
Citadel Advisors LLC
4.82M
5.36%
+4.82M
+1376631.43%
Jun 12, 2025
T. Rowe Price Investment Management, Inc.
3.97M
4.41%
-103.98K
-2.55%
Mar 31, 2025
Adage Capital Management, L.P.
3.63M
4.04%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
2.84M
3.16%
-23.48K
-0.82%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.11M
3.45%
+57.80K
+1.90%
Mar 31, 2025
Bain Capital Life Sciences Investors, LLC
2.76M
3.07%
--
--
Mar 31, 2025
Schonfeld Strategic Advisors LLC
1.66M
1.85%
+1.66M
--
Mar 31, 2025
Cantor Fitzgerald, L.P
1.48M
1.65%
+1.38M
+1384.59%
Mar 31, 2025
Nichtberger (Steven)
1.35M
1.5%
-600.00K
-30.78%
Apr 28, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
iShares Micro-Cap ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
iShares Morningstar Small-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Humankind US Stock ETF
0%
iShares ESG Aware MSCI USA Small-Cap ETF
0%
SPDR Portfolio MSCI Global Stock Market ETF
0%
Ver Mais
iShares Micro-Cap ETF
Proporção0.02%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0%
iShares Russell 2000 ETF
Proporção0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0%
iShares Morningstar Small-Cap ETF
Proporção0%
iShares Core S&P Total U.S. Stock Market ETF
Proporção0%
Humankind US Stock ETF
Proporção0%
iShares ESG Aware MSCI USA Small-Cap ETF
Proporção0%
SPDR Portfolio MSCI Global Stock Market ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
